1H3.SI Clearbridge Health (SES) +100% intraday 03 Apr 2026: volume spike

Clearbridge Health (1H3.SI) surged 100.00% intraday to S$0.002 on 03 Apr 2026 during SES trading, driven by a turnover spike of 24,368,300 shares. The move makes 1H3.SI stock the day’s top gainer on volume nearly five times its average. Intraday range printed S$0.001–S$0.002, suggesting short-covering or a concentrated retail trade. We summarise the drivers, valuation signals and what traders should watch next in this intraday update.

1H3.SI stock intraday snapshot

Price action: Clearbridge Health (1H3.SI) traded between S$0.001 and S$0.002 today and closed at S$0.002 in the SES intraday session. Volume: trade volume hit 24,368,300 shares versus an average of 5,536,821, giving a relative volume of 4.40. Market size: market capitalisation stands at S$8,591,642 with 4,295,820,825 shares outstanding.

Why the jump: trading flow and sector context

One clear driver for the spike in 1H3.SI stock is heavy turnover consistent with short-covering or clustered retail bids. The Healthcare sector in Singapore has shown modest moves today, and Clearbridge’s low float and micro-cap status amplify intraday swings. The stock’s intraday 100.00% gain contrasts with the broader Healthcare 1D move of +0.29%, highlighting company-specific trading flow rather than sector news.

Financials and valuation signals for 1H3.SI stock

Key ratios: Clearbridge reports a price-to-book of 1.91 and price-to-sales of 0.87 (TTM). Earnings: EPS and P/E are N/A due to negative net income per share of -0.00391 (TTM). Cash and balance: cash per share is 0.00030 and book value per share is 0.00159. These figures show thin margins and limited liquidity relative to larger Healthcare peers, supporting the view that valuation moves are sensitive to small trade volumes.

Technical and trading setup for intraday players

Momentum: RSI sits at 53.84, signalling neutral momentum on the intraday timeframe. Moving averages: the 50-day average is around S$0.002 and the 200-day average is S$0.002 on rounded three-decimal view, so price sits near short-term averages. Volume indicators show On-Balance Volume at 46,585,000, consistent with outsized buying. For traders, the immediate support is S$0.001 and resistance is the year high S$0.005.

Meyka AI grade and model forecast for 1H3.SI stock

Meyka AI rates 1H3.SI with a score out of 100: the model returns a 58.28 score, graded C+ with a suggestion to HOLD. This grade factors S&P 500 and sector comparison, financial growth, key metrics and analyst consensus. Meyka AI’s forecast model projects a one-year target of S$0.005. Versus today’s S$0.002, that implies an implied upside of 150.00%. Forecasts are model-based projections and not guarantees.

Risks and what to watch next for 1H3.SI stock

Principal risks: micro-cap liquidity, negative operating margins, and episodic volume spikes that can reverse quickly. Clearbridge has operating cash flow per share negative at -0.00081 (TTM) and interest coverage is negative. Watch upcoming catalysts: any corporate announcements, changes in trading restrictions, or insider transactions. Short-term traders should use tight stops; longer-term investors should await quarterly updates and clearer earnings signals.

Final Thoughts

Key takeaways on 1H3.SI stock: Clearbridge Health rose 100.00% intraday to S$0.002 on 03 Apr 2026 on volume of 24,368,300, a clear sign of concentrated trading activity. Valuation metrics show price-to-book at 1.91 and price-to-sales near 0.87, but EPS and P/E are not meaningful due to negative earnings. Meyka AI’s model projects S$0.005 in one year, implying 150.00% upside from today’s price, though this is a model projection not a guarantee. Given the company’s micro-cap profile, volatile intraday moves can deliver quick gains and quick reversals. Traders should prioritise risk control; longer-term investors should wait for clearer earnings improvement or strategic updates before adding exposure. For live quotes and disclosures visit the company site and our Meyka stock page for real-time tracking

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.